Research that relies on biophysical instrumentation for discovery and cross-validation of lipid ligands and small molecule drug leads for proteins, memteins and native membranes.
Our research involves the application of nutrition and nutrigenetics to the nutraceutical prevention and post-onset management of type 2 diabetes in humans, with a view to the reduction of polypharmacy.